Vranic S，Gatalica Z.病理学在个性化（精度）医学时代的作用：简短的评论。Acta Med Acad。 2021; 50（1）：47–57。 doi：10.5644/ama2006-124.325精确肿瘤学年趋势报告：肿瘤学家，病理学家和付款人的观点。 第七版。 2021。 诺华制药公司。 Accessed July 18, 2024. https://www.hcp.novartis.com/globalassets/migration-root/hcp/care-management-new/assets/mmo-1238785_precision-oncology-annual-trend-report-seventh_ed.pdf Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital癌症诊断中采用病理学；与Pathai的表格许可协议。 新闻稿。 2024年5月1日。 Accessed July 18, 2024. https://newsroom.questdiagnostics.com/2024-05-01-Quest-Diagnostics-to-Acquire-PathAI-Diagnostics-to-Accelerate-AI-and-Digital-Pathology-Adoption-in-Cancer-Diagnosis-Forms- Licensing-Agreements-with-PathAI#Acta Med Acad。2021; 50（1）：47–57。doi：10.5644/ama2006-124.325精确肿瘤学年趋势报告：肿瘤学家，病理学家和付款人的观点。第七版。 2021。 诺华制药公司。 Accessed July 18, 2024. https://www.hcp.novartis.com/globalassets/migration-root/hcp/care-management-new/assets/mmo-1238785_precision-oncology-annual-trend-report-seventh_ed.pdf Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital癌症诊断中采用病理学；与Pathai的表格许可协议。 新闻稿。 2024年5月1日。 Accessed July 18, 2024. https://newsroom.questdiagnostics.com/2024-05-01-Quest-Diagnostics-to-Acquire-PathAI-Diagnostics-to-Accelerate-AI-and-Digital-Pathology-Adoption-in-Cancer-Diagnosis-Forms- Licensing-Agreements-with-PathAI#第七版。2021。诺华制药公司。Accessed July 18, 2024. https://www.hcp.novartis.com/globalassets/migration-root/hcp/care-management-new/assets/mmo-1238785_precision-oncology-annual-trend-report-seventh_ed.pdf Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital癌症诊断中采用病理学；与Pathai的表格许可协议。新闻稿。2024年5月1日。Accessed July 18, 2024. https://newsroom.questdiagnostics.com/2024-05-01-Quest-Diagnostics-to-Acquire-PathAI-Diagnostics-to-Accelerate-AI-and-Digital-Pathology-Adoption-in-Cancer-Diagnosis-Forms- Licensing-Agreements-with-PathAI#